Gilead CAR-T Joins Billion-Dollar Club As Biktarvy Sales Cross $10bn Mark

Veklury Declines As COVID-19 Demand Eases

 
• By Alaric DeArment
  
Gilead Sciences announced its Q4 and FY 2022 earnings on 2 February • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Earnings

More from Business